Pennsylvania Allergy & Asthma Society

  • Home
  • About PAAA
    • Mission and Bylaws
    • Officers and Committees
    • Board of Regents Minutes
    • Legislation and Advocacy
    • Membership
    • Corporate Partners >
      • Support Opportunities
  • Events
    • Virtual Education Programs
    • Annual Meeting >
      • Exhibitor Information
    • Past Event Information >
      • Photo Gallery
  • TRAINEES/TRAINING
  • PAAA Education & Research Fund
    • PAERF Contributors
    • PAERF Posters
    • 2023 Research/Education Grants
  • For the Public
    • What is An Allergist?
    • Common Allergic Diseases
    • Pennsylvania Allergens
  • Member Login
  • NIAID-funded Research
  • Home
  • About PAAA
    • Mission and Bylaws
    • Officers and Committees
    • Board of Regents Minutes
    • Legislation and Advocacy
    • Membership
    • Corporate Partners >
      • Support Opportunities
  • Events
    • Virtual Education Programs
    • Annual Meeting >
      • Exhibitor Information
    • Past Event Information >
      • Photo Gallery
  • TRAINEES/TRAINING
  • PAAA Education & Research Fund
    • PAERF Contributors
    • PAERF Posters
    • 2023 Research/Education Grants
  • For the Public
    • What is An Allergist?
    • Common Allergic Diseases
    • Pennsylvania Allergens
  • Member Login
  • NIAID-funded Research
Picture
Sanofi Genzyme & Regeneron
https://www.sanofi.us/en/
​
https://www.regeneron.com/


About Sanofi Genzyme & Regeneron
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation around the globe. 
​
Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine had led to multiple FDA-approved treatments, almost all of which were homegrown in our laboratories. 
Representatives
Gregg Kristyniak
gregory.kristyniak@regeneron.com
570-903-7835

Tiffany Los
tiffany.los@sanofi.com
215-512-0775

Sophia Benyovsky
sophia.benyovsky@regeneron.com
267-718-1548

Louis Coromilas
louis.coromilas@sanofi.com
267-247-6587
Representatives will be available to meet with attendees at the following times:
Friday, June 25
7:30 a.m. - 7:50 a.m.
10:15 a.m. - 10:45 a.m.
Saturday, June 26
7:30 a.m. - 7:50 a.m.
9:30 a.m. - 10:00 a.m.
11:45 a.m. - 12:15 p.m.
MEET WITH SANOFI GENZYME & REGENERON REPRESENTATIVES
Picture
About Dupixent
DUPIXENT (dupilumab) is currently approved in the US for three indications. Please visit our virtual booth at 
www.dupixenthcp.com/virtualbooth to learn more! 
Resources
Upper-Lower-Airway
Join Us for a Virtual ISS Program
Saturday, June 26 at 2:30 p.m.

Type 2 Inflammation in Asthma, Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP), and Atopic Dermatitis
Speaker: Gregory Bensch, MD

Register to Attend!
This session will be provided on the same link as the PAAA Annual Meeting sessions. If you would like to add it to your registration, click here and enter your email and reference number or email lnewmaster@pamedsoc.org and we will add it to your registration for you. Registration is not required to attend, but will give us an idea of how many attendees to expect. 
RETURN TO EXHIBIT GALLERY
Pennsylvania Allergy and Asthma Association.  All Rights Reserved.
 400 Winding Creek Blvd, Mechanicsburg, PA 17050
Phone: (833) 770-1543 |
paaa@paallergy.org
© 2017, Pennsylvania Allergy & Asthma Association. All rights are reserved.

Contact Us | Privacy Policy | Terms of Use | Sitemap
Picture